Park Ha Biological Technology Securities Lawsuit Opportunity for Investors
Rosen Law Firm, representing investor rights, is notifying purchasers of Park Ha Biological Technology Co., Ltd. securities of a potential lawsuit. The action concerns shares bought between December 27, 2024, and July 8, 2025.
New York – Law firm Rosen Law Firm, specializing in investor rights, has alerted purchasers of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) securities to a potential legal claim. The notice targets investors who acquired the company's securities during the class period from December 27, 2024, through July 8, 2025.
The firm is investigating allegations that the company may have made misleading or false statements to investors during the specified trading period. Investors who incurred losses as a result of these alleged misrepresentations are encouraged to contact the firm before a deadline to preserve their rights.
Potential claims in the lawsuit are expected to relate to information provided about the company's business operations and financial condition. Investors seeking to participate will need to provide documentation of their purchases and any resulting losses.
Rosen Law Firm positions itself as a global entity focused on securities litigation and advancing investor interests. The firm urges all affected parties to seek further details regarding the proceedings and applicable deadlines.